# IBUPROFEN AND FAMOTIDINE
> **ANDA211278** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-10-29
## Drug
- **FDA Application Number:** ANDA211278
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN AND FAMOTIDINE
- **Generic name:** Famotidine
- **Active ingredients:** FAMOTIDINE; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2021-10-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211278)
---
*MORVS · CC0 1.0*